Lensar (LNSR) Cash from Operations (QoQ) (2020 - 2026)
Lensar (LNSR) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.90 Bn | 176.61 Bn | 6.27 Bn |
| 2 | Stryker | 128.85 Bn | 125.97 Bn | 3.81 Bn |
| 3 | Medtronic | 108.77 Bn | 99.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.50 Bn | 44.83 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.35 Bn | 2.07 Bn |
| 10 | Lensar | 66.40 Mn | 55.30 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -791.10% |
| Dec 31, 2025 | 117.59% |
| Sep 30, 2025 | 29.71% |
| Jun 30, 2025 | 27.96% |
| Mar 31, 2025 | -289.72% |
| Dec 31, 2024 | 15.98% |
| Sep 30, 2024 | 183.46% |
| Jun 30, 2024 | 28.81% |
| Mar 31, 2024 | -1,005.63% |
| Dec 31, 2023 | -41.59% |
| Sep 30, 2023 | 84.19% |
| Jun 30, 2023 | 67.98% |
| Mar 31, 2023 | -40.73% |
| Dec 31, 2022 | -1.21% |
| Sep 30, 2022 | -68.49% |
| Jun 30, 2022 | -7.02% |
| Mar 31, 2022 | -252.77% |
| Dec 31, 2021 | 65.61% |
| Sep 30, 2021 | -46.99% |
| Jun 30, 2021 | 68.35% |